Lysosomal Storage Disorders Flashcards
Hurler Syndrome
deficient- a-L-Iduronidase
accumulation- Dermatan sulfate & heparan sulfate
urine postive for GAGS
affects degradation of dermatan/heparin sulfate (deposition in coronary arteries can lead to death)
-corneal clouding, dwarfing, coarse facial features, airway obstruction, hearing loss
iduronidase (enzyme replacement therapy)
Hunter Syndrome
deficient- Iduronate sulfatase
X-linked recessive (predominatly males)
milder form
affects degradation of dermatan/heparin sulfate
- coarse facial features, hepatosplenomegaly, developmental delay
- NO CORNEAL CLOUDING
enzyme replacement therapy
Sphingolipidoses
complex lipids (contain sphingosine as alcohol instead of glycerol) sphingosine + fatty acid = ceramide
two classes
- glycosphingolipids/glycolipid -contain carbohydrate moiety linked to ceramide
- sphingophospholipids contain phosphoryl choline moiety linked to ceramide (sphingomyelin)
Tay-Sachs disease
deficient- B-Hexosaminidase A
accumulation of Ganglioside (Gm2) (ganliosidosis)
- neurodegeneration after 3-6 months, blindess
- cherry read spot on macula
- onion shell incluisons in lysosomes
fatal by 2-6 years
- carriers (heterozygotes) 1 copy of mutant gene, 1 normal gene
- can be detected via enzyme assays
- 50% hexosaminidase activity (phenotypically normal)
Gaucher disease
most common
deficient- B-Glucosidase
accumulation- Glucosyl ceramide (glucocerebroside)
macrophages engorged with glucocerebrosides
adult form (most common)
- no neurological damage
- marked hepatosplenomegaly
- osteoperosis of long bones “erlenmeyer flask femur”
- “bone crisis”
enzyme replacement therapy
Fabry disease
deficient- a-Galactosidase
accumulating- Globoside (ceramide trihexoside)
- peripheral neuropathy (tingling/burning of extremities)
- “acroparesthesias”
globosdie accumulates in blood vessels of skin, kidneys, nerves, and heart
children may have fatal complicaitons (kidney damage, heart attack, stroke)
carrier females can show mild clinical features
Niemann-Pick disease
deficient- Sphingomyelinase
accumulating- Sphingomyelin (sphingophospholipid)
accumulaiton of sphingomyelin in neuronal tissues
Type A
severe infantile forme (fatal by 2-3 years)
cherry-red spot on macula (blindness)
Type B
later in childhood
presents with hepatosplenomegaly
common feature for both types- lipid droplet accumulaiton “foamy cell appearence)
Metachromatic leukodystrophy
deficient- Aryl Sulfatase A
accumulating- Sulfatide (rich in neurons)
-progressive paralysis and demyelination
Pompe disease
deficient- lysosomal acid maltase (1>4 glucosidase)
accumulation of glycogen in heart (cardiac failure), muslce (myophathy), kidney, liver (hepatocellular damage)
(vacuoles in lysosomes) GSD type III
enzyme replacement therapy
I-cell disease (inclusion cell disease)
detect in trafficking enzymes to lysosomes
fails to add mannose-6-P marker
enzymes secreted into blood stream (high concentration of lysosomal enzymes in blood)
deficiency of many lysosomal enzymes
accumulation of GAGS and sphingolipids in lysosomes
presence of intracytoplasmic inclusions in fibroblasts
“inclusion cells” “I-cells”
similar clinical manifestations of Hurler’s yet more severe an onset at earlier age